Pharmaceutical manufacturing

FILE - In this March 22, 2020 file photo, Italian soldiers patrol by closed shops due to lockdown measure to prevent the spread of Covid-19, in Milan, Italy. Italy was the first Western democracy to be hit by the virus, and it has suffered the most deaths of any nation, nearly 14,000, now it is likely to set an example of how to lift restrictions that have imposed the harshest peacetime limits on personal freedom and shut down all non-essential industry. The new coronavirus causes mild or moderate symptoms for most people, but for some, especially older adults and people with existing health problems, it can cause more severe illness or death. (AP Photo/Antonio Calanni, File)
April 10, 2020 - 11:51 pm
SOAVE, Italy (AP) — With warmer weather beckoning, Italians are straining against a strict lockdown to halt the coronavirus that is just now showing signs of ebbing at the end of five weeks of mass isolation. Italy was the first Western democracy to be hit by the virus, and it has suffered the most...
Read More
Police officers stand outside St Thomas' Hospital in the background in central London, where Prime Minister Boris Johnson remains in intensive care as his coronavirus symptoms persist, Wednesday April 8, 2020. Johnson has spent his second night in hospital intensive care. The highly contagious COVID-19 coronavirus has impacted on nations around the globe, many imposing self isolation and exercising social distancing when people move from their homes. (Dominic Lipinski/PA via AP)
Associated Press
April 08, 2020 - 9:05 am
LONDON (AP) — British Prime Minister Boris Johnson is “responding to treatment” but remains in intensive care with the new coronavirus, his spokesman said Wednesday, as the U.K. saw its biggest spike in deaths from the virus to date. A shaken U.K. government sought to keep a grip on its response to...
Read More
In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)
April 06, 2020 - 3:35 pm
The new coronavirus made Dr. Jag Singh a patient at his own hospital. His alarm grew as he saw an X-ray of his pneumonia-choked lungs and colleagues asked his wishes about life support while wheeling him into Massachusetts General’s intensive care unit. When they offered him a chance to help test...
Read More
FILE - In this Nov. 28, 2018, file photo, the Department of Justice seal is seen in Washington, D.C. An internet firm is ending the automated registration of website names that include words or phrases related to the COVID-19 pandemic, in an attempt to combat coronavirus-related fraud. Los Angeles-based Namecheap Inc. made the pledge after a federal judge in Texas on Sunday, March 22, 2020, ordered the takedown of a website the U.S. Department of Justice accused of stealing credit card information while offering fake coronavirus vaccine kits. (AP Photo/Jose Luis Magana, File)
March 26, 2020 - 3:31 pm
BOSTON (AP) — An internet firm is ending the automated registration of website names that include words or phrases related to the COVID-19 pandemic, an attempt to combat coronavirus-related fraud. Los Angeles-based Namecheap Inc. made the pledge after a federal judge in Texas ordered the takedown...
Read More
In this photo released by Saudi Press Agency, SPA, Saudi King Salman, chairs a video call of world leaders from the Group of 20 and other international bodies and organizations, from his office in Riyadh, Saudi Arabia, Thursday, March 26, 2020. The meeting is aimed at coordinating the global response to the fast-spreading coronavirus, which has shuttered businesses and forced well over a quarter of the world's population into home isolation. (Saudi Press Agency via AP)
Associated Press
March 26, 2020 - 12:00 pm
DUBAI, United Arab Emirates (AP) — The head of the United Nations told leaders of the world’s 20 major industrialized nations during an emergency virtual summit Thursday that "we are at war with a virus – and not winning it” despite dramatic measures by countries to seal their borders, shutter...
Read More
FILE - In this July 9, 2015, file photo, a man walks outside the headquarters of Gilead Sciences in Foster City, Calif. Gilead Sciences said Wednesday, March 25, 2020 it will give up the specialty status it received days earlier for its COVID-19 drug amid public outrage that the company was seeking to boost the profits of its treatment. (AP Photo/Eric Risberg, File)
March 25, 2020 - 12:55 pm
WASHINGTON (AP) — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment. Gilead Sciences said it will ask U.S. regulators to revoke the so-...
Read More
FILE - In this Monday, March 2, 2020 file photo, Gilead Sciences CEO Daniel O'Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington. Gilead, the pharmaceutical giant that makes remdesivir, a promising coronavirus drug, has registered it as a rare disease treatment with U.S. regulators on Monday, March 23, 2020, a status that can potentially be worth millions in tax breaks and competition-free sales. (AP Photo/Andrew Harnik)
Associated Press
March 24, 2020 - 6:11 pm
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales. What that specialty status will actually mean for the...
Read More
People walk past a convenient store where the latest cover of a magazine is stuck on a pillar outside of it on Sunday, March 15, 2020, in New York. President Donald Trump on Sunday called on Americans to cease hoarding groceries and other supplies, while one of the nation's most senior public health officials called on the nation to act with more urgency to safeguard their health as the coronavirus outbreak continued to spread across the United States. (AP Photo/Wong Maye-E)
March 16, 2020 - 3:52 pm
Millions of people are stocking up and holing up at home a as a growing number of governments fight to bring the coronavirus under control. The number of reported cases worldwide topped 175,000 with 6,700 deaths. More than 77,000 people have recovered from the illness. These are some of the latest...
Read More
Dr. Lisa Jackson, a senior investigator at the Kaiser Permanente Washington Health Research Institute, works in her office with an image of COVID-19 taped to her door, Sunday, March 15, 2020, in Seattle. Jackson is leading the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, which was given to the first volunteer in the study by injection, Monday, March 16. (AP Photo/Ted S. Warren)
March 16, 2020 - 9:37 am
SEATTLE (AP) — U.S. researchers gave the first shot to the first person in a test of an experimental coronavirus vaccine Monday -- leading off a worldwide hunt for protection even as the pandemic surges. With a careful jab in a healthy volunteer’s arm, scientists at the Kaiser Permanente Washington...
Read More
March 16, 2020 - 8:06 am
BERLIN (AP) — A German company working on a potential vaccine for the new coronavirus denied reports Monday that the U.S. government was angling to acquire it, while German officials sought to ease tensions fueled by the story by insisting the firm would stay in the country. On Sunday, Germany's...
Read More

Pages